JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
The content, articles and product information provided on this website are strictly educational and informational. They are intended to be used for in vitro research only. “In vitro” is a Latin phrase, “in glass,” that refers to research that is conducted outside of a living organism. Note, these products are not pharmaceuticals or medicines and have not been approved by the FDA for the diagnosis, treatment or prevention of any illnesses or disorders. These products are legally prohibited from human or animal consumption.
Epithalon is a tetrapeptide (Ala-Glu-Asp-Gly) extensively characterized in laboratory cell culture systems for its interactions with telomerase enzymatic pathways and neuroprotective signalling mechanisms. Published in vitro research demonstrates its molecular interactions through telomerase repeat amplification protocol (TRAP) assays, telomere length quantification methodologies, and pineal gland-derived cellular pathway modulation. Research protocols utilize defined cell model systems under controlled laboratory conditions to characterize binding affinity profiles, enzyme kinetics, and downstream cellular signalling cascade activation.
Epithalon demonstrates measurable activity through telomerase reverse transcriptase (TERT) enzymatic pathway engagement in cultured cell systems. TRAP assay methodologies reveal concentration-dependent activation of telomerase enzymatic activity, with kinetic parameters indicating specific binding interactions with the telomerase holoenzyme complex. Fluorescence-based telomere length quantification assays demonstrate dose-response relationships in various immortalized cell line models, including HeLa, U-2 OS, and primary human fibroblast cultures.
Enzyme kinetics studies indicate Epithalon modulates telomerase activity through allosteric regulatory mechanisms rather than direct catalytic site binding. Time-course experiments reveal maximal enzymatic activation occurring within 24-48 hours of peptide exposure in cell culture conditions, with sustained activity measurable for 72-96 hours post-treatment in standard laboratory incubation protocols.
Cell-based assays utilizing pinealocyte culture systems demonstrate Epithalon interactions with melatonin biosynthetic pathway components. Enzyme-linked immunosorbent assay (ELISA) methodologies reveal modulation of N-acetyltransferase (NAT) and hydroxyindole-O-methyltransferase (HIOMT) enzymatic activities in cultured pineal cells. Quantitative PCR analysis indicates upregulation of clock gene expression patterns, particularly Period1 (PER1) and Cryptochrome1 (CRY1) transcript levels.
Radioligand binding assays demonstrate specific interactions with MT1 and MT2 melatonin receptor subtypes, exhibiting binding affinities in the nanomolar range. Competition binding studies reveal non-competitive inhibition patterns, suggesting allosteric modulation sites distinct from endogenous melatonin binding domains.
Cell viability assays utilizing neuroblastoma cell lines (SH-SY5Y, SK-N-SH) demonstrate cytoprotective effects under oxidative stress conditions induced by hydrogen peroxide exposure. Flow cytometry analysis reveals reduced reactive oxygen species (ROS) generation and maintained mitochondrial membrane potential in peptide-treated cell populations.
Western blot analysis indicates upregulation of antioxidant enzyme expression, including catalase, superoxide dismutase, and glutathione peroxidase. Enzyme activity assays confirm functional increases in antioxidant capacity, with glutathione-S-transferase activity showing 40-60% enhancement in treated cell cultures compared to control conditions.
Annexin V/propidium iodide flow cytometry protocols reveal reduced apoptotic cell populations in neuronal culture systems exposed to pro-apoptotic stimuli. Caspase activity assays demonstrate inhibition of caspase-3 and caspase-9 enzymatic activity, indicating interference with intrinsic apoptotic pathway activation.
Mitochondrial cytochrome c release assays show preservation of mitochondrial membrane integrity under stress conditions. ATP quantification using bioluminescent methodologies indicates maintained cellular energy metabolism in peptide-treated cultures subjected to metabolic stress protocols.
Primary hippocampal neuron cultures derived from embryonic tissue demonstrate enhanced dendritic branching complexity following peptide exposure, quantified through Sholl analysis methodologies. Electrophysiological recordings reveal maintained synaptic transmission parameters and action potential generation capacity under stress conditions.
Calcium imaging studies utilizing Fura-2 fluorescent indicators demonstrate modulation of intracellular calcium homeostasis, with reduced calcium overload responses to excitotoxic stimuli. Patch-clamp electrophysiology reveals stabilization of membrane potential and ionic conductance properties.
HEK293 and CHO cell expression systems transfected with relevant receptor constructs enable detailed pharmacological characterization of peptide-receptor interactions. Luciferase reporter assays demonstrate downstream signalling pathway activation through cAMP response element binding protein (CREB) and nuclear factor kappa B (NF-κB) transcriptional mechanisms.
In vitro pharmacological characterization establishes Epithalon as a bioactive tetrapeptide with measurable interactions across multiple cellular pathway systems. Telomerase enzymatic activation represents the primary mechanism of action, with supporting evidence for pineal pathway modulation and neuroprotective signalling engagement. Cell model studies demonstrate concentration-dependent responses with nanomolar binding affinities and sustained enzymatic effects. These findings provide foundational data for understanding peptide-cellular interactions in controlled laboratory environments, contributing to the broader understanding of telomerase biology and neuroprotective mechanisms in cell culture systems.
All content is intended for in vitro laboratory research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any condition.
Forgot password?
Country: United States (US-only registration)
All products on this site are for Research, Development use only. Products are Not for Human consumption of any kind. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
ElementSarms is a chemical supplier. ElementSarms is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. ElementSarms is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.